These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37118834)

  • 1. Association of polypharmacy with all-cause mortality and adverse events among elderly colorectal cancer survivors.
    Choi DW; Kang H; Zhang HS; Jhang H; Jeong W; Park S
    Cancer; 2023 Sep; 129(17):2705-2716. PubMed ID: 37118834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Polypharmacy with Colorectal Cancer Survival Among Older Patients.
    Chen LJ; Nguyen TNM; Chang-Claude J; Hoffmeister M; Brenner H; Schöttker B
    Oncologist; 2021 Dec; 26(12):e2170-e2180. PubMed ID: 34476870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Effects of Frailty and Polypharmacy on Health Outcomes in Older Adults: Frailty Outweighs Polypharmacy.
    Chen YZ; Huang ST; Wen YW; Chen LK; Hsiao FY
    J Am Med Dir Assoc; 2021 Mar; 22(3):606.e7-606.e18. PubMed ID: 32873474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentially inappropriate medication use in older patients with breast and colorectal cancer.
    Karuturi MS; Holmes HM; Lei X; Johnson M; Barcenas CH; Cantor SB; Gallick GE; Bast RC; Giordano SH
    Cancer; 2018 Jul; 124(14):3000-3007. PubMed ID: 29689595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.
    Hong S; Lee JH; Chun EK; Kim KI; Kim JW; Kim SH; Lee YG; Hwang IG; Kim JY; Koh SJ; Ko YH; Shin SH; Woo IS; Kim TY; Baek JY; Kim HJ; Kim HJ; Lee MA; Kwon JH; Hong YS; Ryoo HM; Kim JH
    Oncologist; 2020 Mar; 25(3):e502-e511. PubMed ID: 32162799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of polypharmacy and potentially inappropriate medications on treatment and posttreatment courses in elderly patients with head and neck cancer.
    Park JW; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    J Cancer Res Clin Oncol; 2016 May; 142(5):1031-40. PubMed ID: 26744323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic role of polypharmacy in metastatic colorectal cancer patients treated with regorafenib.
    Yekedüz E; Aktaş EG; Köksoy EB; Doğan N; Ürün Y; Utkan G
    Future Oncol; 2022 Mar; 18(9):1067-1076. PubMed ID: 35109668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of hospitalization in an acute geriatric unit on polypharmacy and potentially inappropriate prescriptions: A retrospective study.
    Gutiérrez-Valencia M; Izquierdo M; Malafarina V; Alonso-Renedo J; González-Glaría B; Larrayoz-Sola B; Monforte-Gasque MP; Latasa-Zamalloa P; Martínez-Velilla N
    Geriatr Gerontol Int; 2017 Dec; 17(12):2354-2360. PubMed ID: 28422415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of polypharmacy on all-cause mortality and hospitalization in incident hemodialysis patients: a cohort study.
    Toida T; Toida R; Takahashi R; Uezono S; Komatsu H; Sato Y; Fujimoto S
    Clin Exp Nephrol; 2021 Nov; 25(11):1215-1223. PubMed ID: 34129133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frailty, Polypharmacy, and Health Outcomes in Older Adults: The Frailty and Dependence in Albacete Study.
    Bonaga B; Sánchez-Jurado PM; Martínez-Reig M; Ariza G; Rodríguez-Mañas L; Gnjidic D; Salvador T; Abizanda P
    J Am Med Dir Assoc; 2018 Jan; 19(1):46-52. PubMed ID: 28899661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Modifiable Health Conditions and Social Determinants of Health With Late Mortality in Survivors of Childhood Cancer.
    Ehrhardt MJ; Liu Q; Dixon SB; Caron E; Redd D; Shelton K; Huang IC; Bhakta N; Ness KK; Mulrooney DA; Brinkman TM; Chemaitilly W; Delaney A; Armstrong GT; Srivastava DK; Zaidi A; Robison LL; Yasui Y; Hudson MM
    JAMA Netw Open; 2023 Feb; 6(2):e2255395. PubMed ID: 36763361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frailty and polypharmacy in the community-dwelling elderly with multiple chronic diseases.
    Chuang YN; Chen CC; Wang CJ; Chang YS; Liu YH
    Psychogeriatrics; 2023 Mar; 23(2):337-344. PubMed ID: 36717278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis.
    Jyrkkä J; Enlund H; Korhonen MJ; Sulkava R; Hartikainen S
    Drugs Aging; 2009; 26(6):493-503. PubMed ID: 19591524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypharmacy and Unplanned Hospitalizations in Patients with Rheumatoid Arthritis.
    Filkova M; Carvalho J; Norton S; Scott D; Mant T; Molokhia M; Cope A; Galloway J
    J Rheumatol; 2017 Dec; 44(12):1786-1793. PubMed ID: 28966210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in long-term survivors of colorectal cancer and its association with all-cause mortality: a German cohort study.
    Ratjen I; Schafmayer C; Enderle J; di Giuseppe R; Waniek S; Koch M; Burmeister G; Nöthlings U; Hampe J; Schlesinger S; Lieb W
    BMC Cancer; 2018 Nov; 18(1):1156. PubMed ID: 30466408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between polypharmacy and health-related quality of life among cancer survivors in the United States.
    Babcock ZR; Kogut SJ; Vyas A
    J Cancer Surviv; 2020 Feb; 14(1):89-99. PubMed ID: 31792811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypharmacy, potentially inappropriate medications and drug-drug interactions in geriatric patients with hematologic malignancy: Observational single-center study of 122 patients.
    Leger DY; Moreau S; Signol N; Fargeas JB; Picat MA; Penot A; Abraham J; Laroche ML; Bordessoule D
    J Geriatr Oncol; 2018 Jan; 9(1):60-67. PubMed ID: 28851511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse Outcomes in Relation to Polypharmacy in Robust and Frail Older Hospital Patients.
    Poudel A; Peel NM; Nissen LM; Mitchell CA; Gray LC; Hubbard RE
    J Am Med Dir Assoc; 2016 Aug; 17(8):767.e9-767.e13. PubMed ID: 27373672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypharmacy, comorbidity and frailty: a complex interplay in older patients at the emergency department.
    van Dam CS; Labuschagne HA; van Keulen K; Kramers C; Kleipool EE; Hoogendijk EO; Knol W; Nanayakkara PWB; Muller M; Trappenburg MC; Peters MJL
    Eur Geriatr Med; 2022 Aug; 13(4):849-857. PubMed ID: 35723840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of comprehensive geriatric assessment for frail elderly patients operated for colorectal cancer-the colorectal cancer frailty study: study protocol for a randomized, controlled, multicentre trial.
    Normann M; Ekerstad N; Angenete E; Prytz M
    Trials; 2022 Nov; 23(1):948. PubMed ID: 36397083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.